Advertisement
U.S. markets close in 46 minutes

Better Therapeutics, Inc. (BTTX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
0.0148+0.0019 (+14.73%)
As of 02:53PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0129
Open0.0130
Bid0.2035 x 800
Ask0.2100 x 1100
Day's Range0.0127 - 0.0160
52 Week Range0.0120 - 1.6100
Volume881,549
Avg. Volume6,756,972
Market Cap806,830
Beta (5Y Monthly)2.35
PE Ratio (TTM)N/A
EPS (TTM)-1.1000
Earnings DateMar 28, 2024 - Apr 01, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for BTTX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Better Therapeutics, Inc.
    Daily – Vickers Top Insider Picks for 03/03/2022The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Rating
    Fair Value
    Economic Moat
    2 years agoArgus Research
View more